Patents by Inventor Montserrat Gallego Luengo

Montserrat Gallego Luengo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended release venlafaxine besylate tablets
    Patent number: 7776358
    Abstract: Venlafaxine besylate is formulated into an extended release tablet in high loading rates by use of a coating that contains ammonio methacrylate copolymer(s).
    Type: Grant
    Filed: July 22, 2004
    Date of Patent: August 17, 2010
    Assignee: Synthon IP Inc.
    Inventors: Joan Cucala Escoi, Montserrat Gallego Luengo, Inocencia Margallo Lana
  • Modified calcium phosphate excipient
    Patent number: 7364755
    Abstract: Calcium phosphate modified with a fatty acid wax in a weight ratio of 50:50 to 95:5, respectively, is useful as an excipient.
    Type: Grant
    Filed: July 2, 2004
    Date of Patent: April 29, 2008
    Assignee: Synthon IP Inc.
    Inventors: Joan Cucala Escoi, Montserrat Gallego Luengo, Arturo Siles Ortega
  • Extended release venlafaxine besylate tablets
    Publication number: 20060018963
    Abstract: Venlafaxine besylate is formulated into an extended release tablet in high loading rates by use of a coating that contains ammonio methacrylate copolymer(s).
    Type: Application
    Filed: July 22, 2004
    Publication date: January 26, 2006
    Inventors: Joan Cucala Escoi, Montserrat Gallego Luengo, Inocencia Margallo Lana
  • Modified release venlafaxine hydrochloride tablets
    Publication number: 20050048118
    Abstract: A modified release tablet of venlafaxine hydrochloride is formed by a core containing a lipophilic matrix and venlafaxine hydrochloride and a water-insoluble, permeable coating thereover.
    Type: Application
    Filed: July 22, 2004
    Publication date: March 3, 2005
    Inventors: Joan Cucala Escoi, Montserrat Gallego Luengo, Inocencia Margallo Lana
  • Modified calcium phosphate excipient
    Publication number: 20050031682
    Abstract: Calcium phosphate modified with a fatty acid wax in a weight ratio of 50:50 to 95:5, respectively, is useful as an excipient.
    Type: Application
    Filed: July 2, 2004
    Publication date: February 10, 2005
    Inventors: Joan Cucala Escoi, Montserrat Gallego Luengo, Arturo Siles Ortega
  • Venlafaxine besylate
    Patent number: 6717015
    Abstract: Venlafaxine besylate compounds provide certain advantages over venlafaxine hydrochloride and are useful in forming pharmaceutical compositions and n treating venlafaxine-treatable diseases and conditions. Venlafaxine besylate can be easily formulated into an extended release dosage form including a hydrogel tablet as well as other matrix-based tablet compositions. A preferred tablet making process involves hot melt granulation.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: April 6, 2004
    Assignee: Synthon BV
    Inventors: Rolf Keltjens, Johannes Jan Platteeuw, Juan Cucala Escoi, Inocencia Margallo Lana, Frantisek Picha, Montserrat Gallego Luengo
  • Venlafaxine besylate
    Publication number: 20030195249
    Abstract: Venlafaxine besylate compounds provide certain advantages over venlafaxine hydrochloride and are useful in forming pharmaceutical compositions and n treating venlafaxine-treatable diseases and conditions. Venlafaxine besylate can be easily formulated into an extended release dosage form including a hydrogel tablet as well as other matrix-based tablet compositions. A preferred tablet making process involves hot melt granulation.
    Type: Application
    Filed: March 27, 2003
    Publication date: October 16, 2003
    Applicant: SYNTHON BV
    Inventors: Rolf Keltjens, Johannes Jan Platteeuw, Juan Cucala Escoi, Inocencia Margallo Lana, Frantisek Picha, Montserrat Gallego Luengo
  • Compositions of venlafaxine base
    Publication number: 20030190352
    Abstract: Solid venlafaxine base can be advantageously employed in making pharmaceutical compositions, especially extended release compositions.
    Type: Application
    Filed: March 27, 2003
    Publication date: October 9, 2003
    Applicant: SYNTHON BV
    Inventors: Juan Cucala Escoi, Montserrat Gallego Luengo, Marinus J. M. Oosterbaan, Frantisek Picha